---
title: "CytoSorbents holds annual shareholder meeting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295970326.md"
description: "CytoSorbents held its annual shareholder meeting on Aug. 13, 2026. Shareholders approved a charter amendment allowing a reverse stock split with a ratio between 1-for-5 and 1-for-20 within one year. The company also ratified WithumSmith+Brown as its independent auditor for the fiscal year ending Dec. 31, 2026. An authorization to adjourn the meeting was granted but not required."
datetime: "2026-08-14T20:11:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295970326.md)
  - [en](https://longbridge.com/en/news/295970326.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295970326.md)
generator: "portal-rs"
---

# CytoSorbents holds annual shareholder meeting

-   CytoSorbents held its annual shareholder meeting on Aug. 13, 2026. \* Shareholders backed a charter amendment authorizing a reverse stock split, with the board to set a ratio between 1-for-5 and 1-for-20 within one year. \* Holders ratified WithumSmith+Brown as independent registered public accounting firm for the year ending Dec. 31, 2026. \* Investors also authorized an adjournment if needed to solicit more proxies, though no adjournment was required. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoSorbents Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-097092), on August 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CTSO.US](https://longbridge.com/en/quote/CTSO.US.md)

## Related News & Research

- [CytoSorbents releases investor presentation on blood purification devices for ICU, cardiac surgery use](https://longbridge.com/en/news/296280537.md)
- [CytoSorbents posts investor presentation outlining Q2 revenue, cash burn progress toward breakeven](https://longbridge.com/en/news/295602568.md)
- [Valion Bio amends 8-K to report final vote tally on reverse stock split approval](https://longbridge.com/en/news/296531983.md)
- [LPSN: Adjournment was approved to reconvene on September 2nd after insufficient votes for the merger](https://longbridge.com/en/news/296507504.md)
- [Tempest Therapeutics special meeting adjourned after proposal fell short of required votes](https://longbridge.com/en/news/296266762.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**